Your browser doesn't support javascript.
loading
Plasma anti-FXa concentration after continuous intravenous infusion and subcutaneous dosing of enoxaparin for thromboprophylaxis in critically ill patients. A randomized clinical trial.
Vahtera, Annukka; Valkonen, Miia; Huhtala, Heini; Pettilä, Ville; Kuitunen, Anne.
Affiliation
  • Vahtera A; Tampere University Hospital, Critical Care Medicine Research Group, PO Box 2000, 33521 Tampere, Finland. Electronic address: annukka.vahtera@pshp.fi.
  • Valkonen M; Division of Intensive Care Medicine, Department of Anesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Huhtala H; Faculty of Social Sciences, University of Tampere, Tampere, Finland.
  • Pettilä V; Division of Intensive Care Medicine, Department of Anesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Kuitunen A; Tampere University Hospital, Critical Care Medicine Research Group, PO Box 2000, 33521 Tampere, Finland.
Thromb Res ; 158: 71-75, 2017 Oct.
Article in En | MEDLINE | ID: mdl-28846877
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombosis / Critical Illness / Enoxaparin / Factor Xa Inhibitors / Anticoagulants Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Thromb Res Year: 2017 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombosis / Critical Illness / Enoxaparin / Factor Xa Inhibitors / Anticoagulants Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Thromb Res Year: 2017 Document type: Article Country of publication: United States